The Effects of Xenon and Nitrous Oxide Gases on Alcohol Relapse

Alcoholism: Clinical and Experimental Research

Volumn 38, Issue 2, 2014, Pages 557-563

  Vengeliene, Valentina ^a   Bessiere, Baptiste ^b   Pype, Jan ^b   Spanagel, Rainer ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b AIR LIQUIDE   (France)

Author keywords

Alcohol Deprivation Effect; Cue Induced Reinstatement of Alcohol Seeking Behavior; Nitrous Oxide; Rat; Relapse; Xenon

Indexed keywords

ALCOHOL; NITROUS OXIDE; XENON;

ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSOCIATION; CONTROLLED STUDY; DRINKING BEHAVIOR; DRUG EFFECT; DRUG SEEKING BEHAVIOR; ENVIRONMENTAL EXPOSURE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RELAPSE;

RATTUS; RATTUS NORVEGICUS;

ALCOHOL DEPRIVATION EFFECT; CUE-INDUCED REINSTATEMENT OF ALCOHOL-SEEKING BEHAVIOR; NITROUS OXIDE; RAT; RELAPSE; XENON;

ALCOHOLISM; ANESTHETICS, INHALATION; ANIMALS; ATMOSPHERE EXPOSURE CHAMBERS; CONDITIONING, OPERANT; CUES; DRUG-SEEKING BEHAVIOR; EXTINCTION, PSYCHOLOGICAL; MALE; MOTOR ACTIVITY; NITROUS OXIDE; RATS; RATS, WISTAR; RECURRENCE; SELF ADMINISTRATION; SUBSTANCE WITHDRAWAL SYNDROME; XENON;

EID: 84893700685     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/acer.12264     Document Type: Article

References (46)

1. Benturquia N, Le Guen S, Canestrelli C, Lagente V, Apiou G, Roques BP, Noble F (2007) Specific blockade of morphine- and cocaine-induced reinforcing effects in conditioned place preference by nitrous oxide in mice. Neuroscience 149:477-486.
2. Benturquia N, Le Marec T, Scherrmann JM, Noble F (2008) Effects of nitrous oxide on dopamine release in the rat nucleus accumbens and expectation of reward. Neuroscience 155:341-344.
3. 2O) exposure leads to persistent alleviation of neuropathic pain in rats. J Pain 11:13-23.
4. Bessière B, Laboureyras E, Laulin JP, Simonnet G (2010b) Xenon prevents inflammation-induced delayed pain hypersensitivity in rats. NeuroReport 21:1167-1171.
5. Burish TG, Maisto SA, Cooper AM, Sobell MB (1981) Effects of voluntary short-term abstinence from alcohol on subsequent drinking patterns of college students. J Stud Alcohol 42:1013-1020.
6. Cannady R, Fisher KR, Durant B, Besheer J, Hodge CW (2013) Enhanced AMPA receptor activity increases operant alcohol self-administration and cue-induced reinstatement. Addict Biol 18:54-65.
7. Carlson AP, Brown AM, Zager E, Uchino K, Marks MP, Robertson C, Sinson GP, Marmarou A, Yonas H (2011) Xenon-enhanced cerebral blood flow at 28% xenon provides uniquely safe access to quantitative, clinically useful cerebral blood flow information: a multicenter study. AJNR Am J Neuroradiol 32:1315-1320.
8. David HN, Ansseau M, Lemaire M, Abraini JH (2006) Nitrous oxide and xenon prevent amphetamine-induced carrier-mediated dopamine release in a memantine-like fashion and protect against behavioral sensitization. Biol Psychiatry 60:49-57.
9. Dinse A, Föhr KJ, Georgieff M, Beyer C, Bulling A, Weigt HU (2005) Xenon reduces glutamate-, AMPA- and kainate-induced membrane currents in cortical neurons. Br J Anaesth 94:479-485.
10. Drummond GB, Bleach L, Thomson AJ, Kennedy RR (2012) Kinetics of anesthetic onset measured with a direct index of neural activity. Anesth Analg 115:547-553.
11. Engblom D, Bilbao A, Sanchis-Segura C, Dahan L, Perreau-Lenz S, Balland B, Parkitna JR, Luján R, Halbout B, Mameli M, Parlato R, Sprengel R, Lüscher C, Schütz G, Spanagel R (2008) Glutamate receptors on dopamine neurons control the persistence of cocaine seeking. Neuron 59:497-508.
12. Franks JJ, Horn JL, Janicki PK, Singh G (1995) Halothane, isoflurane, xenon, and nitrous oxide inhibit calcium ATPase pump activity in rat brain synaptic plasma membranes. Anesthesiology 82:108-117.
13. Franks NP, Dickinson R, deSousa SL, Hall AC, Lieb WR (1998) How does xenon produce anesthesia? Nature 396:324.
14. Fukura H, Kitani Y, Komiya Y, Igarashi M (2000) Nitrous oxide, but not xenon, affects the signaling in the neuronal growth cone. Prog Neuropsychopharmacol Biol Psychiatry 24:1357-1368.
15. Füllgrabe MW, Vengeliene V, Spanagel R (2007) Influence of age at drinking onset on the alcohol deprivation effect and stress-induced drinking in female rats. Pharmacol Biochem Behav 86:320-326.
16. Gruss MG, Bushell TJ, Bright DP, Lieb AR, Mathie A, Franks NP (2004) Two-pore-domain K+ channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane. Mol Pharmacol 65:443-452.
17. Hapfelmeier G, Zieglgänsberger W, Haseneder R, Schneck H, Kochs E (2000) Nitrous oxide and xenon increase the efficacy of GABA at recombinant mammalian GABA(A) receptors. Anesth Analg 91:1542-1549.
18. Hölter SM, Spanagel R (1999) Effects of opiate antagonist treatment on the alcohol deprivation effect in long-term ethanol-experienced rats. Psychopharmacology 145:360-369.
19. Hornbein TF, Eger EI 2nd, Winter PM, Smith G, Wetstone D, Smith KH (1982) The minimum alveolar concentration of nitrous oxide in man. Anesth Analg 61:553-556.
20. Jevtović-Todorović V, Todorović SM, Mennerick S, Powell S, Dikranian K, Benshoff N, Zorumski CF, Olney JW (1998) Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin. Nat Med 4:460-463.
21. Koblin DD, Fang Z, Eger EI 2nd, Laster MJ, Gong D, Ionescu P, Halsey MJ, Trudell JR (1998) Minimum alveolar concentrations of noble gases, nitrogen, and sulfur hexafluoride in rats: helium and neon as nonimmobilizers (nonanesthetics). Anesth Analg 87:419-424.
22. Krystal JH, Petrakis IL, Mason G, Trevisan L, D'Souza DC (2003) N-methyl-D-aspartate glutamate receptors and alcoholism: reward, dependence, treatment, and vulnerability. Pharmacol Ther 99:79-94.
23. Liu LT, Xu Y, Tang P (2010) Mechanistic insights into xenon inhibition of NMDA receptors from MD simulations. J Phys Chem B 114:9010-9016.
24. Ma D, Hossain M, Pettet GK, Luo Y, Lim T, Akimov S, Sanders RD, Franks NP, Maze M (2006) Xenon preconditioning reduces brain damage from neonatal asphyxia in rats. J Cereb Blood Flow Metab 26:199-208.
25. Mameli M, Halbout B, Creton C, Engblom D, Parkitna JR, Spanagel R, Lüscher C (2009) Cocaine-evoked synaptic plasticity: persistence in the VTA triggers adaptations in the NAc. Nat Neurosci 12:1036-1041.
26. Mennerick S, Jevtovic-Todorovic V, Todorovic SM, Shen W, Olney JW, Zorumski CF (1998) Effect of nitrous oxide on excitatory and inhibitory synaptic transmission in hippocampal cultures. J Neurosci 18:9716-9726.
27. Nakata Y, Goto T, Ishiguro Y, Terui K, Kawakami H, Santo M, Niimi Y, Morita S (2001) Minimum alveolar concentration (MAC) of xenon with sevoflurane in humans. Anesthesiology 94:611-614.
28. Preckel B, Weber NC, Sanders RD, Maze M, Schlack W (2006) Molecular mechanisms transducing the anesthetic, analgesic, and organ-protective actions of xenon. Anesthesiology 105:187-197.
29. Salimov RM, Salimova NB (1993) The alcohol deprivation effect in hybrid mice. Drug Alcohol Depend 32:187-191.
30. Samson HH (1986) Initiation of ethanol reinforcement using a sucrose-substitution procedure in food- and water-sated rats. Alcohol Clin Exp Res 10:436-442.
31. Sanchis-Segura C, Borchardt T, Vengeliene V, Zghoul T, Bachteler D, Gass P, Sprengel R, Spanagel R (2006) Involvement of the AMPA receptor GluR-C subunit in alcohol-seeking behavior and relapse. J Neurosci 26:1231-1238.
32. Sanchis-Segura C, Spanagel R (2006) Behavioural assessment of drug-reinforcement and addictive features in rodents: an overview. Addict Biol 11:2-38.
33. Santos M, Kuncar V, Martínez-Taboada F, Tendillo FJ (2005) Large concentrations of nitrous oxide decrease the isoflurane minimum alveolar concentration sparing effect of morphine in the rat. Anesth Analg 100:404-408.
34. Shaham Y, Shalev U, Lu L, De Wit H, Stewart J (2003) The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology 168:3-20.
35. Sinclair JD (1971) The alcohol-deprivation effect in monkeys. Psychon Sci 25:21-22.
36. Sinclair JD, Senter RJ (1967) Increased preference for ethanol in rats following alcohol deprivation. Psychonom Sci 8:11-12.
37. Spanagel R (2009) Alcoholism: a systems approach from molecular physiology to addictive behavior. Physiol Rev 89:649-705.
38. Spanagel R, Hölter SM (1999) Long-term alcohol self-administration with repeated alcohol deprivation phases: an animal model of alcoholism? Alcohol Alcohol 34:231-243.
39. Spanagel R, Vengeliene V (2013) New pharmacological treatment strategies for relapse prevention. Curr Top Behav Neurosci 13:583-609.
40. Tsai G, Coyle JT (1998) The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Annu Rev Med 49:173-184.
41. Valleggi S, Cavazzana AO, Bernardi R, Ma D, Natale G, Maze M, Cattano D, Giunta F (2008) Xenon up-regulates several genes that are not up-regulated by nitrous oxide. J Neurosurg Anesthesiol 20:226-232.
42. Vengeliene V, Bachteler D, Danysz W, Spanagel R (2005) The role of the NMDA receptor in alcohol relapse: a pharmacological mapping study using the alcohol deprivation effect. Neuropharmacology 48:822-829.
43. Vengeliene V, Bilbao A, Molander A, Spanagel R (2008) Neuropharmacology of alcohol addiction. Br J Pharmacol 154:299-315.
44. Vengeliene V, Celerier E, Chaskiel L, Penzo F, Spanagel R (2009) Compulsive alcohol drinking in rodents. Addict Biol 14:384-396.
45. Vengeliene V, Leonardi-Essmann F, Sommer WH, Marston HM, Spanagel R (2010) Glycine transporter-1 blockade leads to persistently reduced relapse-like alcohol drinking in rats. Biol Psychiatry 68:704-711.
46. Yamakura T, Harris RA (2000) Effects of gaseous anesthetics nitrous oxide and xenon on ligand-gated ion channels. Comparison with isoflurane and ethanol. Anesthesiology 93:1095-1101.